1. Home
  2. CYCC vs TC Comparison

CYCC vs TC Comparison

Compare CYCC & TC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CYCC
  • TC
  • Stock Information
  • Founded
  • CYCC 1992
  • TC 2010
  • Country
  • CYCC United States
  • TC China
  • Employees
  • CYCC 12
  • TC N/A
  • Industry
  • CYCC Biotechnology: Pharmaceutical Preparations
  • TC Business Services
  • Sector
  • CYCC Health Care
  • TC Consumer Discretionary
  • Exchange
  • CYCC Nasdaq
  • TC Nasdaq
  • Market Cap
  • CYCC 2.2M
  • TC 1.9M
  • IPO Year
  • CYCC N/A
  • TC 2018
  • Fundamental
  • Price
  • CYCC $0.36
  • TC $1.00
  • Analyst Decision
  • CYCC Strong Buy
  • TC
  • Analyst Count
  • CYCC 1
  • TC 0
  • Target Price
  • CYCC $11.00
  • TC N/A
  • AVG Volume (30 Days)
  • CYCC 6.4M
  • TC 178.2K
  • Earning Date
  • CYCC 11-12-2024
  • TC 08-30-2024
  • Dividend Yield
  • CYCC N/A
  • TC N/A
  • EPS Growth
  • CYCC N/A
  • TC N/A
  • EPS
  • CYCC N/A
  • TC N/A
  • Revenue
  • CYCC $74,000.00
  • TC $14,107,804.00
  • Revenue This Year
  • CYCC N/A
  • TC N/A
  • Revenue Next Year
  • CYCC $88.68
  • TC N/A
  • P/E Ratio
  • CYCC N/A
  • TC N/A
  • Revenue Growth
  • CYCC N/A
  • TC N/A
  • 52 Week Low
  • CYCC $0.31
  • TC $0.75
  • 52 Week High
  • CYCC $4.00
  • TC $4.30
  • Technical
  • Relative Strength Index (RSI)
  • CYCC 43.22
  • TC 49.11
  • Support Level
  • CYCC $0.34
  • TC $0.88
  • Resistance Level
  • CYCC $0.39
  • TC $1.03
  • Average True Range (ATR)
  • CYCC 0.08
  • TC 0.10
  • MACD
  • CYCC 0.00
  • TC -0.01
  • Stochastic Oscillator
  • CYCC 6.30
  • TC 32.43

About CYCC Cyclacel Pharmaceuticals Inc.

Cyclacel Pharmaceuticals Inc is a clinical-stage biopharmaceutical company that develops targeted medicines for cancer and other proliferative diseases. The company develops several families of anticancer drugs that act on the cell cycle, including CDK (cyclin-dependent kinase) inhibitors, and PLK (polo-like kinase) inhibitors. The pipeline development programs of the company include fadraciclib, Sapacitabine, and plogosertib.

About TC TuanChe Limited

TuanChe Ltd is an omnichannel automotive marketplace in China. The company operates in one operating segment of providing auto shows, special promotion events services, and virtual dealership, online marketing services, and others. It organizes auto shows, which aim at facilitating transactions between consumers and auto dealers that include auto dealers, automakers, and automotive service providers. It provides services through its online platform and offline events.

Share on Social Networks: